đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
This study will evaluate safety, reactogenicity and immunogenicity of GSK B...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08-07
Trial ID
NCT00344318
Treatments Being Tested
The purpose of the study is to evaluate the immunogenicity and reactogenici...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-03-01
Trial ID
NCT01086423
Treatments Being Tested
The purpose of this booster study is to evaluate the immune persistence in ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-10-01
Trial ID
NCT01449812
Treatments Being Tested
The study will evaluate the safety and reactogenicity of PoliorixTM given a...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-01
Trial ID
NCT00920439
Treatments Being Tested
The purpose of the study is to assess the immunogenicity and safety of thre...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05-13
Trial ID
NCT01106092
Treatments Being Tested
The purpose of the study is to evaluate the immunogenicity and safety of Po...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-11-28
Trial ID
NCT01021293
Treatments Being Tested
This study will evaluate the persistence of immune response against diphthe...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-04-01
Trial ID
NCT01323959
Treatments Being Tested